Cite

HARVARD Citation

    Kroon, J. et al. (2016). Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer. Endocrine-related cancer. 23 (1), pp. 35-45. [Online]. 
  
Back to record